Image

Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy

Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy

Recruiting
65 years and older
All
Phase 1/2
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The objective of this study is to demonstrate the impact of a socially assistive robot system on reducing apathy among cognitively impaired older adults residing in long term care facilities. Earlier phases of this project demonstrated the feasibility and acceptability of the robotic system. First, investigators will improve the social robotic interaction architecture through additional software development, enhance its versatility, and make it easy for non-experts to run. Second, 188 participants will be randomized to either usual activity programs at the long term care facility, or the usual activity programs plus the robotic activities. Researchers will examine the effect on apathy and also plan on examining underlying individual and facility factors that influence the impact of the robotic activities.

Eligibility

Inclusion Criteria:

  • Residing >3 months in long term care facility
  • Evidence of mild cognitive impairment (SAGE score 15-16), mild dementia (SAGE score <15, AD8<2, DSRD<19), or moderate dementia (SAGE <15, AD8>1, DSRD 19-36)
  • Symptoms of apathy (Score 30+ on AES-C)

Exclusion Criteria:

  • Severe cognitive impairment
  • Physically unable to participate
  • Unable to provide assent
  • Uncorrected vision or hearing
  • Never spoke English
  • Unable to sit comfortably in chair
  • Acutely ill, terminally ill or unresponsive
  • Unable to be moved to activity location
  • Aggressive or combative

Study details
    Alzheimer Disease

NCT05178992

Vanderbilt University

22 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.